Literature DB >> 19632990

Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition.

Ying Jie Ma1, Andrea Doni, Tina Hummelshøj, Christian Honoré, Antonio Bastone, Alberto Mantovani, Nicole M Thielens, Peter Garred.   

Abstract

The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition molecule that is crucial in innate immune protection against opportunistic fungal pathogens such as Aspergillus fumigatus. The mechanisms that mediate downstream effects of PTX3 are largely unknown. However, PTX3 interacts with C1q from the classical pathway of the complement. The ficolins are recognition molecules of the lectin complement pathway sharing structural and functional characteristics with C1q. Thus, we investigated whether the ficolins (Ficolin-1, -2, and -3) interact with PTX3 and whether the complexes are able to modulate complement activation on A. fumigatus. Ficolin-2 could be affinity-isolated from human plasma on immobilized PTX3. In binding studies, Ficolin-1 and particularly Ficolin-2 interacted with PTX3 in a calcium-independent manner. Ficolin-2, but not Ficolin-1 and Ficolin-3, bound A. fumigatus directly, but this binding was enhanced by PTX3 and vice versa. Ficolin-2-dependent complement deposition on the surface of A. fumigatus was enhanced by PTX3. A polymorphism in the FCN2 gene causing a T236M amino acid change in the fibrinogen-like binding domain of Ficolin-2, which affects the binding to GlcNAc, reduced Ficolin-2 binding to PTX3 and A. fumigatus significantly. These results demonstrate that PTX3 and Ficolin-2 may recruit each other on pathogens. The effect was alleviated by a common amino acid change in the fibrinogen-like domain of Ficolin-2. Thus, components of the humoral innate immune system, which activate different complement pathways, cooperate and amplify microbial recognition and effector functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632990      PMCID: PMC2788878          DOI: 10.1074/jbc.M109.009225

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.

Authors:  Cecilia Garlanda; Emilio Hirsch; Silvia Bozza; Antonietta Salustri; Marika De Acetis; Rachele Nota; Alessia Maccagno; Federica Riva; Barbara Bottazzi; Giuseppe Peri; Andrea Doni; Luca Vago; Marina Botto; Rita De Santis; Paolo Carminati; Gregorio Siracusa; Fiorella Altruda; Annunciata Vecchi; Luigina Romani; Alberto Mantovani
Journal:  Nature       Date:  2002-11-14       Impact factor: 49.962

Review 4.  Membrane and cell wall targets in Aspergillus fumigatus.

Authors:  A Beauvais; J P Latgé
Journal:  Drug Resist Updat       Date:  2001-02       Impact factor: 18.500

5.  Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

Authors:  Alma J Nauta; Barbara Bottazzi; Alberto Mantovani; Giovanni Salvatori; Uday Kishore; Wilhelm J Schwaeble; Alexandre R Gingras; Sotiria Tzima; Fernando Vivanco; Jesús Egido; Odette Tijsma; Erik C Hack; Mohamed R Daha; Anja Roos
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

6.  Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement.

Authors:  Young Gerl Ma; Mi Yhang Cho; Mingyi Zhao; Ji Won Park; Misao Matsushita; Teizo Fujita; Bok Luel Lee
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

7.  Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein.

Authors:  Flemming Larsen; Hans O Madsen; Robert B Sim; Claus Koch; Peter Garred
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

8.  L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement.

Authors:  Nicholas J Lynch; Silke Roscher; Thomas Hartung; Siegfried Morath; Misao Matsushita; Daniela N Maennel; Mikio Kuraya; Teizo Fujita; Wilhelm J Schwaeble
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

9.  Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals.

Authors:  Roberta Gaziano; Silvia Bozza; Silvia Bellocchio; Katia Perruccio; Claudia Montagnoli; Lucia Pitzurra; Giovanni Salvatori; Rita De Santis; Paolo Carminati; Alberto Mantovani; Luigina Romani
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

10.  Local inflammation induces complement crosstalk which amplifies the antimicrobial response.

Authors:  Jing Zhang; Jingyun Koh; Jinhua Lu; Steffen Thiel; Benjamin S H Leong; Sunil Sethi; Cynthia Y X He; Bow Ho; Jeak L Ding
Journal:  PLoS Pathog       Date:  2009-01-30       Impact factor: 6.823

View more
  69 in total

1.  Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.

Authors:  Luis Perea; Mar Coll; Lucia Sanjurjo; Delia Blaya; Adil El Taghdouini; Daniel Rodrigo-Torres; José Altamirano; Isabel Graupera; Beatriz Aguilar-Bravo; Marta Llopis; Julia Vallverdú; Joan Caballeria; Leo A van Grunsven; Maria-Rosa Sarrias; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2017-07-18       Impact factor: 17.425

2.  The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2.

Authors:  Antonio Inforzato; Clair Baldock; Thomas A Jowitt; David F Holmes; Ragnar Lindstedt; Marcella Marcellini; Vincenzo Rivieccio; David C Briggs; Karl E Kadler; Antonio Verdoliva; Barbara Bottazzi; Alberto Mantovani; Giovanni Salvatori; Anthony J Day
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria.

Authors:  Saswati Panda; Jing Zhang; Nguan Soon Tan; Bow Ho; Jeak Ling Ding
Journal:  EMBO J       Date:  2013-09-03       Impact factor: 11.598

Review 4.  Innate recognition of fungal cell walls.

Authors:  Stuart M Levitz
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

5.  Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Markus M Simon; Reinhard Wallich
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

Review 6.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

7.  Role of ficolin-A and lectin complement pathway in the innate defense against pathogenic Aspergillus species.

Authors:  Stefan Bidula; Hany Kenawy; Youssif M Ali; Darren Sexton; Wilhelm J Schwaeble; Silke Schelenz
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

8.  Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo.

Authors:  E Hein; L Munthe-Fog; A S Thiara; A E Fiane; T E Mollnes; P Garred
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

9.  Commercially available complement component-depleted sera are unexpectedly codepleted of ficolin-2.

Authors:  Allison M Brady; K Aaron Geno; Alex G Dalecki; Xiaogang Cheng; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2014-07-16

10.  Serum opsonin ficolin-A enhances host-fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge.

Authors:  Stefan Bidula; Darren W Sexton; Silke Schelenz
Journal:  Med Microbiol Immunol       Date:  2015-09-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.